Sitemap
April 13, 2009 Articles
Filter by Available Specialty
- Benefit of endocrine therapy plus radiotherapy outweigh QOL risks in prostate cancer
- Board recommends continuation of phase 3 Iluvien implant study
- Freddie H. Fu named president of ISAKOS
- Nitten Pharmaceutical to commercialize AzaSite in Japan, Taiwan
- Othera announces positive preliminary results for topical geographic atrophy drug
- Patients, staff may have been exposed to TB at several Chicago hospitals
- Patients, staff may have been exposed to TB at several Chicago hospitals
- Presurgical stress management sessions improved mood, QOL after prostatectomy
- Study shows associations between uveal melanoma and iris nevi, cutaneous nevi and freckles
- The piggyback IOL to the rescue
- U.S. smoking reduction trends may not meet 2010 Healthy People goal
- Vitamin D insufficiency rising, racial and ethnic disparities persist